NERV (Minerva Neurosciences) GF Score: 32/100 (As of Jul. 03, 2026) — 11% Below Median


NERV Minerva Neurosciences Inc NERV
32 GF Score
Price $5.11
! 1 Warning Sign
View Full Analysis

What is Minerva Neurosciences GF Score?

Minerva Neurosciences NERV -0.97% 32 GF Score is 32 as of Jul. 03, 2026, which is 11% below its 10-year median of 36.00. GuruFocus rates NERV with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

Minerva Neurosciences has the GF Score of 32, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 5/10
2. Profitability Rank : 2/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 6/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Minerva Neurosciences might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Minerva Neurosciences  (NAS:NERV) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Minerva Neurosciences GF Score Related Terms

NERV vs TTRX, WHWK, IMUX: GF Score Comparison

For the Biotechnology subindustry, Minerva Neurosciences's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Minerva Neurosciences GF Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Minerva Neurosciences's GF Score distribution charts can be found below:

* The bar in red indicates where Minerva Neurosciences's GF Score falls into.


NERV
32GF Score
Minerva Neurosciences Inc NERV
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 32 mean?
Minerva Neurosciences (NERV) has a GF Score of 32 as of Jul. 03, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Minerva Neurosciences and its competitors. This is 11% below median its historical median of 36.00. Over the past decade, Minerva Neurosciences' GF Score has ranged from 19.00 to 46.00.
Is Minerva Neurosciences' GF Score too high?
Minerva Neurosciences' current GF Score of 32 is 11% below median its 10-year median of 36.00. Over the past 10 years, this metric has ranged from a low of 19.00 to a high of 46.00. Overall, Minerva Neurosciences has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Minerva Neurosciences' GF Score compare to TTRX and WHWK?
Minerva Neurosciences' GF Score of 32 can be compared against companies in the Biotechnology industry. Historically, Minerva Neurosciences' own GF Score has ranged from 19.00 to 46.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Minerva Neurosciences and its competitors. Minerva Neurosciences's current GF Score is 32, which is 11% below median its own 10-year median of 36.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minerva Neurosciences stock overvalued right now?
Minerva Neurosciences (NERV) has a current GF Score of 32. The current GF Score is 32, which is 11% below median its 10-year median of 36.00. Minerva Neurosciences' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Minerva Neurosciences (NERV), the current GF Score is 32 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minerva Neurosciences Business Description

Other Exchanges 4MNA:Germany
Address 1500 District Avenue, Burlington, MA, USA, 01803
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.
32GF Score

Get the complete analysis for NERV

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.11
Price